DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Avience Biomedicals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 4 hrs ago·21 Jul 2026, 10:58 am

AVIENCE NSE

Avience Biomedicals has announced it will hold an investor conference call on July 24, 2026. The meeting is scheduled for 4:00 PM IST and will be used to discuss the company's audited standalone and consolidated financial results for the half year and the full financial year ending March 31, 2026.

This update is significant for investors as it provides an opportunity to hear management's perspective on the company's performance and future outlook directly. It allows shareholders to understand the factors driving the results and assess the company's trajectory ahead of the official announcement.

Investors should watch for management commentary on operational efficiency, debt levels, and strategic initiatives during the call. This information will be crucial for evaluating the company's health and making informed decisions regarding their holdings.